Search results for

At the MARQUES Luxury Brands Symposium in Hong Kong, the topic on everyone’s lips was “branding in China”

In German, Peter Stiefel’s last name means “boot”. The boot fits; at the MARQUES panel on defending luxury brands last week, Stiefel seemed by far the most gung-ho of the speakers, and the most willing to kick down doors in search of counterfeits

The 15th edition of Managing IP's annual publication devoted to IP in China tracks the Middle Kingdom's shifting IP law landscape. Significant progress has been made in protecting works of applied art and curbing bad faith filing. Readers may be especially interested to learn about China's change of heart on business method patents.

Managing IP hosted an awards dinner, on March 23, at the Four Seasons in Washington DC to reveal the winners of the North America Awards 2017

Section 10 of the Lanham Act contains an anti-trafficking rule which prohibits the assignment of an intent-to-use-based trade mark application except where such assignment is to a successor to the business of the applicant or portion thereof to which the mark pertains. This provision played a key role in a decision recently rendered by the US Court of Appeals for the Federal Circuit in Emerald Cities Collaborative, Inc v Sheri Jean Roese. This ruling serves as an important reminder about the laws prohibiting the assignment of intent-to-use based trade mark applications, the risks in pursuing enforcement efforts when a mark might not have been properly assigned and the importance of asserting common law rights in a notice of opposition.

It is natural to expect that when a company files a patent application it wants to obtain a patent, maintain it and obtain some profit from it. Sometimes the natural course of things is disrupted.

It has been approximately a decade since the Mexican Institute of Industrial Property (IMPI) adopted very strict criteria when assessing the likelihood of confusion between trade marks. As a result of this strict approach IMPI's trade mark examiners had some criteria that were troublesome, especially when marks including designs or associated to a concept were compared to each other.

Debiopharm International SA, the appellant, owns a patent for an invention titled "pharmaceutically stable oxaliplatinum preparation". Debiopharm was granted registrations of patent term extension (PTE) for the patent based on approvals provided in the Pharmaceutical Affairs Law for "ELPLAT I.V. Infusion Solution" which is oxaliplatin (equal to oxaliplatinum) preparations. Towa Pharmaceutical Co, Ltd, the appellee, manufactured and sold generic drugs of ELPLAT. Debiopharm sought an injunction on manufacturing, etc of Towa's products alleging that the effect of the extended patent right covers the manufacturing and selling of those products.

Apple has had its trade mark Sherlock revoked by the Intellectual Property Office of Singapore in a recent case which reinforces the need for trade mark owners to establish evidence of genuine use of their mark – or risk losing it.

Cases of counterfeiting, IP infringement and low-standard goods handled by MSD Vietnamese authorities have stepped up their efforts to enforce IP rights in recent years, particularly in 2016, and especially in the area of combating counterfeit goods.